The Role of Rac-1 Inhibitor in Management of Acute Pancreatitis and Regulation of Chemokine in rat’s model
Keywords:
Rac-1, Chemokines, acute pancreatitis, Inflammation, and leukocyteAbstract
Background: Acute pancreatitis is a common inflammatory disease of the exocrine pancreas, characterized by a mortality rate ranging from 1% to 5%. This condition has the potential to lead to organ dysfunction, pancreatic necrosis, and subsequent organ failure. Aim: Rac1, a G-protein with a molecular weight of approximately 21 kD, has been demonstrated to govern various platelet functions. We hypothesized that the inhibition of Rac-1 signaling could be implicated in severe acute pancreatitis (AP). Our study aimed to explore the impact of a Rac- 1 inhibitor on decrease of lipase enzyme and chemokine (IL-6 and CXCL1), and its potential in safeguarding against tissue damage associated with severe acute pancreatitis. Method: In this experimental study, male albino rats were employed, and the rats received pretreatment with a specific Rac1 inhibitor, NSC23766, at a dosage of 5 mg/kg. Subsequently, a midline laparotomy was performed on the anesthetized animals, followed by L-arginine injection intra-peritoneally. Blood Lipase levels were measured, and the concentration of serum chemokines (IL6 and CXCL1) were assessed using ELISA. Additionally, leukocyte counting, and histopathological examination were conducted to analyze morphological changes in the pancreas. Results: The blood lipase levels were notably elevated in rats with acute pancreatitis compared to the control rats. Our findings indicated that acute pancreatitis was induced in rats through L-arginine injection. Rac1 expression was upregulated in rats with acute pancreatitis, and pre-treatment with Rac-1 led to a non-significant decrease in lipase levels compared to the acute pancreatitis group. Furthermore, the levels of IL6 and CXCL1 were higher in acute pancreatitis group compared to the control group. Conclusion: Our investigation underscores the pivotal role of Rac-1 in regulating lipase activity during severe acute pancreatitis (AP). Additionally, it highlights the involvement of Rac-1 in platelet activation and the secretion of chemokines, namely IL6 and CXCL1, attributed to inflammation in organ tissues during acute pancreatitis. Targeting Rac1 emerges as a promising and innovative approach for the treatment of severe acute pancreatitis, offering potential control over inflammation and tissue damage
Downloads
Metrics
References
K. Ley et al., “Neutrophils: New insights and open questions,” Sci. Immunol., vol. 3, no. 30, p. eaat4579, 2018.
J. Walkowska, N. Zielinska, R. S. Tubbs, M. Podgorski, J. Dłubek-Ruxer, and Ł. Olewnik, “Diagnosis and treatment of acute pancreatitis,” Diagnostics, vol. 12, no. 8, p. 1974, 2022.
N. Reusch et al., “Neutrophils in COVID-19,” Front. Immunol., vol. 12, p. 652470, 2021.
K. Ley, C. Laudanna, M. I. Cybulsky, and S. Nourshargh, “Getting to the site of inflammation: the leukocyte adhesion cascade updated,” Nat. Rev. Immunol., vol. 7, no. 9, pp. 678–689, 2007.
Y. Chen et al., “Melatonin induces anti-inflammatory effects to play a protective role via endoplasmic reticulum stress in acute pancreatitis,” Cell. Physiol. Biochem., vol. 40, no. 5, pp. 1094–1104, 2016.
F. Mouawad, H. Tsui, and T. Takano, “Role of Rho-GTPases and their regulatory proteins in glomerular podocyte function,” Can. J. Physiol. Pharmacol., vol. 91, no. 10, pp. 773–782, 2013.
R. Hwaiz et al., “Rac1 signaling regulates sepsis-induced pathologic inflammation in the lung via attenuation of Mac-1 expression and CXC chemokine formation,” J. Surg. Res., vol. 183, no. 2, pp. 798–807, 2013.
L. A. Martinez, “Effects of Regulating Rac1 in a Mouse Model of Fragile X Syndrome,” 2016.
Y. Hong et al., “Effects of castanospermine on inflammatory response in a rat model of experimental severe acute pancreatitis,” Arch. Med. Res., vol. 47, no. 6, pp. 436–445, 2016.
O. Z. Ismail and V. Bhayana, “Lipase or amylase for the diagnosis of acute pancreatitis?,” Clin. Biochem., vol. 50, no. 18, pp. 1275–1280, 2017.
X. Wu et al., “Protective effect of tetrandrine on sodium taurocholateinduced severe acute pancreatitis,” Evid. Based Complement. Alternat. Med., vol. 2015, 2015.
T. Plusczyk, S. Westermann, D. Rathgeb, and G. Feifel, “Acute pancreatitis in rats: effects of sodium taurocholate, CCK-8, and Sec on pancreatic microcirculation,” Am. J. Physiol.-Gastrointest. Liver Physiol., vol. 272, no. 2, pp. G310–G320, 1997.
P. Xu et al., “Pioglitazone attenuates the severity of sodium taurocholateinduced severe acute pancreatitis,” World J. Gastroenterol. WJG, vol. 13, no. 13, p. 1983, 2007.
M. E. Soliman, M. A. Kefafy, M. A. Mansour, A. F. Ali, and W. A. I. I. Esa, “Histological study on the possible protective effect of pentoxifylline on pancreatic acini of l-arginine-induced acute pancreatitis in adult male albino rats,” Menoufia Med. J., vol. 27, no. 4, p. 801, 2014.
X.-X. Hong et al., “Systemic injury caused by taurocholate induced severe acute pancreatitis in rats,” Exp. Ther. Med., vol. 24, no. 1, pp. 1– 12, 2022.
Y. Wang, Y. Li, S. Gao, X. Yu, Y. Chen, and Y. Lin, “Tetrahedral framework nucleic acids can alleviate taurocholate-induced severe acute pancreatitis and its subsequent multiorgan injury in mice,” Nano Lett., vol. 22, no. 4, pp. 1759–1768, 2022.
E. Seyhun et al., “Tauroursodeoxycholic acid reduces endoplasmic reticulum stress, acinar cell damage, and systemic inflammation in acute pancreatitis,” Am. J. Physiol.-Gastrointest. Liver Physiol., vol. 301, no. 5, pp. G773–G782, 2011.
Z. Yang, X. Meng, and P. Xu, “Central role of neutrophil in the pathogenesis of severe acute pancreatitis,” J. Cell. Mol. Med., vol. 19, no. 11, pp. 2513–2520, 2015.
G. G. Schiattarella et al., “Rac1 modulates endothelial function and platelet aggregation in diabetes mellitus,” J. Am. Heart Assoc., vol. 7, no. 8, p. e007322, 2018.
Z. Hasan et al., “Rho-kinase signaling regulates pulmonary infiltration of neutrophils in abdominal sepsis via attenuation of CXC chemokine formation and Mac-1 expression on neutrophils,” Shock, vol. 37, no. 3, pp. 282–288, 2012.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
